76 min listen
Episode 36
FromBiotech Hangout
ratings:
Length:
59 minutes
Released:
Nov 7, 2022
Format:
Podcast episode
Description
Lots of news this week! Daphne, Josh and Ethan discuss key binary events of the week, consolidation and the loss of ~40 companies across the industry over the last several months, deals – including the Agios royalty deal, the Sumitomo and Myovant merger and Vaxcyte’s large $690 million offering – as well as Taysha’s criticism around developing ultra-rare diseases and parents getting rights to drugs they helped fund. The hosts also discuss notable earnings from large companies, key FDA actions on Ipsen’s ultra-rare disease and accelerated approval for J&J’s bispecific antibody, and the microbiome coming back into favor.
Released:
Nov 7, 2022
Format:
Podcast episode
Titles in the series (72)
Episode 32 by Biotech Hangout